Dr Rajiv Modi, Chairman and Managing Director of Cadila Pharmaceuticals, inaugurates iamicon 2013 with a riveting speech

Cadila Pharmaceuticals Ltd.’s, Chairman and Managing Director, Dr Rajiv Modi inaugurates IAMICON 2013. Named after the visionary founder chairman of Cadila, Indravadan A. Modi, the conclave is a celebration of science. IAMICON made its debut in 2013 with conclave being held in 33 cities across India and saw a participation of more than 9000 doctors. Dr Modi narrates the Cadila Pharmaceuticals’ journey from its humble beginnings to being the first organization to bring about an innovation in tuberculosis in nearly three decades, with Polycap. He also goes on to announce the launch of Mycidac-C, the first novel drug for lung cancer management in India.

Watch the full speech here.